Usefulness of Dual-Time Point Imaging After Carbonated Water for the Fluorodeoxyglucose Positron Emission Imaging of Peritoneal Carcinomatosis in Colon Cancer

Fluorodeoxygluose (FDG) positron emission/computed tomography (PET/CT) is emerging as a useful tool for the diagnosis of peritoneal carcinomatosis (PC). In this study, we assessed whether dual-time point imaging can improve the accuracy of FDG PET/CT for the diagnosis of PC after colon rectal cancer...

Full description

Saved in:
Bibliographic Details
Published inCancer biotherapy & radiopharmaceuticals Vol. 28; no. 1; pp. 29 - 33
Main Authors Filippi, Luca, D'Arienzo, Marco, Scopinaro, Francesco, Salvatori, Rita, Bagni, Oreste
Format Journal Article
LanguageEnglish
Published New Rochelle, NY Liebert 01.02.2013
Mary Ann Liebert, Inc
Subjects
Online AccessGet full text
ISSN1084-9785
1557-8852
1557-8852
DOI10.1089/cbr.2012.1179

Cover

Loading…
Abstract Fluorodeoxygluose (FDG) positron emission/computed tomography (PET/CT) is emerging as a useful tool for the diagnosis of peritoneal carcinomatosis (PC). In this study, we assessed whether dual-time point imaging can improve the accuracy of FDG PET/CT for the diagnosis of PC after colon rectal cancer (CRC). Thirty-nine patients with past history of CRC were evaluated. Whole-Body PET/CT scan was acquired 1 hour after tracer injection. If one or more focal areas of increased FDG uptake (standardized uptake value, SUV max>2.5) were found in the abdomen, 1 L of carbonated water was orally administered to patients and a delayed scan of the abdominal region was acquired at 2 hours. The SUV max and the mean Delta (Δ) SUV were calculated. The scintigraphic results were compared with the results of colonoscopy and histology and with the clinical follow-up. Thirteen out of the 39 patients did not show any significant area of FDG uptake at the whole-body scan. The remaining 26 patients showed an overall number of 27 sites of focal increased uptake, showing a mean SUV max of 6.5+3.3. Late scan of the abdomen showed vanishing spots in 11 cases. Focal and increasing FDG uptake was found in 15 subjects (for an overall number of 16 sites) with SUV max of 15.6+4 and mean Δ SUV of +26.3%±7.5%. In these cases, final diagnosis was PC in 10 patients (according to cytology or histology) and dysplastic polyp in 5 cases. No significant difference in Δ SUV was found between patients with PC and those with polypoid formations. According to our results, dual-time point imaging after carbonated water may increase the accuracy of FDG PET/CT for the imaging of PC in patients affected by CRC.
AbstractList Background: Fluorodeoxygluose (FDG) positron emission/computed tomography (PET/CT) is emerging as a useful tool for the diagnosis of peritoneal carcinomatosis (PC). In this study, we assessed whether dual-time point imaging can improve the accuracy of FDG PET/CT for the diagnosis of PC after colon rectal cancer (CRC). Methods: Thirty-nine patients with past history of CRC were evaluated. Whole-Body PET/CT scan was acquired 1 hour after tracer injection. If one or more focal areas of increased FDG uptake (standardized uptake value, SUV max>2.5) were found in the abdomen, 1 L of carbonated water was orally administered to patients and a delayed scan of the abdominal region was acquired at 2 hours. The SUV max and the mean Delta (Δ) SUV were calculated. The scintigraphic results were compared with the results of colonoscopy and histology and with the clinical follow-up. Results: Thirteen out of the 39 patients did not show any significant area of FDG uptake at the whole-body scan. The remaining 26 patients showed an overall number of 27 sites of focal increased uptake, showing a mean SUV max of 6.5+3.3. Late scan of the abdomen showed vanishing spots in 11 cases. Focal and increasing FDG uptake was found in 15 subjects (for an overall number of 16 sites) with SUV max of 15.6+4 and mean Δ SUV of +26.3%±7.5%. In these cases, final diagnosis was PC in 10 patients (according to cytology or histology) and dysplastic polyp in 5 cases. No significant difference in Δ SUV was found between patients with PC and those with polypoid formations. Conclusions: According to our results, dual-time point imaging after carbonated water may increase the accuracy of FDG PET/CT for the imaging of PC in patients affected by CRC.
Fluorodeoxygluose (FDG) positron emission/computed tomography (PET/CT) is emerging as a useful tool for the diagnosis of peritoneal carcinomatosis (PC). In this study, we assessed whether dual-time point imaging can improve the accuracy of FDG PET/CT for the diagnosis of PC after colon rectal cancer (CRC). Thirty-nine patients with past history of CRC were evaluated. Whole-Body PET/CT scan was acquired 1 hour after tracer injection. If one or more focal areas of increased FDG uptake (standardized uptake value, SUV max>2.5) were found in the abdomen, 1 L of carbonated water was orally administered to patients and a delayed scan of the abdominal region was acquired at 2 hours. The SUV max and the mean Delta (Δ) SUV were calculated. The scintigraphic results were compared with the results of colonoscopy and histology and with the clinical follow-up. Thirteen out of the 39 patients did not show any significant area of FDG uptake at the whole-body scan. The remaining 26 patients showed an overall number of 27 sites of focal increased uptake, showing a mean SUV max of 6.5+3.3. Late scan of the abdomen showed vanishing spots in 11 cases. Focal and increasing FDG uptake was found in 15 subjects (for an overall number of 16 sites) with SUV max of 15.6+4 and mean Δ SUV of +26.3%±7.5%. In these cases, final diagnosis was PC in 10 patients (according to cytology or histology) and dysplastic polyp in 5 cases. No significant difference in Δ SUV was found between patients with PC and those with polypoid formations. According to our results, dual-time point imaging after carbonated water may increase the accuracy of FDG PET/CT for the imaging of PC in patients affected by CRC.
Fluorodeoxygluose (FDG) positron emission/computed tomography (PET/CT) is emerging as a useful tool for the diagnosis of peritoneal carcinomatosis (PC). In this study, we assessed whether dual-time point imaging can improve the accuracy of FDG PET/CT for the diagnosis of PC after colon rectal cancer (CRC).BACKGROUNDFluorodeoxygluose (FDG) positron emission/computed tomography (PET/CT) is emerging as a useful tool for the diagnosis of peritoneal carcinomatosis (PC). In this study, we assessed whether dual-time point imaging can improve the accuracy of FDG PET/CT for the diagnosis of PC after colon rectal cancer (CRC).Thirty-nine patients with past history of CRC were evaluated. Whole-Body PET/CT scan was acquired 1 hour after tracer injection. If one or more focal areas of increased FDG uptake (standardized uptake value, SUV max>2.5) were found in the abdomen, 1 L of carbonated water was orally administered to patients and a delayed scan of the abdominal region was acquired at 2 hours. The SUV max and the mean Delta (Δ) SUV were calculated. The scintigraphic results were compared with the results of colonoscopy and histology and with the clinical follow-up.METHODSThirty-nine patients with past history of CRC were evaluated. Whole-Body PET/CT scan was acquired 1 hour after tracer injection. If one or more focal areas of increased FDG uptake (standardized uptake value, SUV max>2.5) were found in the abdomen, 1 L of carbonated water was orally administered to patients and a delayed scan of the abdominal region was acquired at 2 hours. The SUV max and the mean Delta (Δ) SUV were calculated. The scintigraphic results were compared with the results of colonoscopy and histology and with the clinical follow-up.Thirteen out of the 39 patients did not show any significant area of FDG uptake at the whole-body scan. The remaining 26 patients showed an overall number of 27 sites of focal increased uptake, showing a mean SUV max of 6.5+3.3. Late scan of the abdomen showed vanishing spots in 11 cases. Focal and increasing FDG uptake was found in 15 subjects (for an overall number of 16 sites) with SUV max of 15.6+4 and mean Δ SUV of +26.3%±7.5%. In these cases, final diagnosis was PC in 10 patients (according to cytology or histology) and dysplastic polyp in 5 cases. No significant difference in Δ SUV was found between patients with PC and those with polypoid formations.RESULTSThirteen out of the 39 patients did not show any significant area of FDG uptake at the whole-body scan. The remaining 26 patients showed an overall number of 27 sites of focal increased uptake, showing a mean SUV max of 6.5+3.3. Late scan of the abdomen showed vanishing spots in 11 cases. Focal and increasing FDG uptake was found in 15 subjects (for an overall number of 16 sites) with SUV max of 15.6+4 and mean Δ SUV of +26.3%±7.5%. In these cases, final diagnosis was PC in 10 patients (according to cytology or histology) and dysplastic polyp in 5 cases. No significant difference in Δ SUV was found between patients with PC and those with polypoid formations.According to our results, dual-time point imaging after carbonated water may increase the accuracy of FDG PET/CT for the imaging of PC in patients affected by CRC.CONCLUSIONSAccording to our results, dual-time point imaging after carbonated water may increase the accuracy of FDG PET/CT for the imaging of PC in patients affected by CRC.
Author Scopinaro, Francesco
D'Arienzo, Marco
Bagni, Oreste
Filippi, Luca
Salvatori, Rita
Author_xml – sequence: 1
  givenname: Luca
  surname: Filippi
  fullname: Filippi, Luca
  organization: Section of Nuclear Medicine, Santa Maria Goretti Hospital, Latina, Italy
– sequence: 2
  givenname: Marco
  surname: D'Arienzo
  fullname: D'Arienzo, Marco
  organization: ENEA, National Institute of Ionizing Radiation Metrology, Rome, Italy
– sequence: 3
  givenname: Francesco
  surname: Scopinaro
  fullname: Scopinaro, Francesco
  organization: Section of Nuclear Medicine, Sant'Andrea Hospital, Rome, Italy
– sequence: 4
  givenname: Rita
  surname: Salvatori
  fullname: Salvatori, Rita
  organization: Section of Nuclear Medicine, Santa Maria Goretti Hospital, Latina, Italy
– sequence: 5
  givenname: Oreste
  surname: Bagni
  fullname: Bagni, Oreste
  organization: Section of Nuclear Medicine, Santa Maria Goretti Hospital, Latina, Italy
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27090714$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/23134220$$D View this record in MEDLINE/PubMed
BookMark eNptkk9rHSEUxYeS0vxpl90WoRS6mVevzjx1GaZJGwg0i4QuxXH01eBoqg4kX6aftQ55j0Loyov-zrn3yjltjkIMpmneA94A5uKLHtOGYCAbACZeNSfQ96zlvCdHtca8awXj_XFzmvM9xniLt-xNc0wo0I4QfNL8ucvGLj6YnFG06OuifHvrZoNuogsFXc1q58IOndtiEhpUGmNQxUzop1ovbEyo_DLo0i8xxcnEx6edX3TMqz67kmJAF7PL2dXi4FXb3JjkSt1D-dVTuxBnVaogIxfQEH2lBxW0SW-b11b5bN7tz7Pm7vLidvjeXv_4djWcX7ea9lBavR2pAEYIaGY6GPmkOo5p35ERCBbEMjVpLihYsEJgzjo8gbCAle4pmzA9az4_-z6k-Hsxucg6tTbeq2DikiUQRikHuiUV_fgCvY9LCnU6Wd-3tO9ro0p92FPLOJtJPiQ3q_QkDz9fgU97QGWtvE11X5f_cQwLzKCrHH3mdIo5J2OldkWV-qElKeclYLnmQNYcyDUHcs1BVbUvVAfj__N_AXEUtFA
CODEN CBRAFJ
CitedBy_id crossref_primary_10_1007_s40336_022_00534_4
crossref_primary_10_1007_s41365_017_0294_8
crossref_primary_10_1016_j_nucmedbio_2014_08_011
crossref_primary_10_1089_cbr_2014_1612
crossref_primary_10_1007_s00261_015_0418_8
Cites_doi 10.1097/01.RLU.0000067510.43457.52
10.1097/PAS.0b013e318205df36
10.1111/j.1749-6632.2011.06077.x
10.1016/S1095-0397(99)00016-3
10.1007/s00330-009-1527-y
10.2967/jnumed.108.057307
10.1089/108497804773391621
10.2214/AJR.09.2936
10.1016/S0016-5085(99)70278-7
10.1055/s-1999-270
10.1016/S0016-5085(97)70119-7
10.1097/00003072-199802000-00008
10.1097/00042737-200209000-00010
10.1055/s-0038-1625195
ContentType Journal Article
Copyright 2014 INIST-CNRS
(©) Copyright 2013, Mary Ann Liebert, Inc.
Copyright_xml – notice: 2014 INIST-CNRS
– notice: (©) Copyright 2013, Mary Ann Liebert, Inc.
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QP
7T5
7TK
7X7
7XB
88A
88E
88I
8C1
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M1P
M2P
M7P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
DOI 10.1089/cbr.2012.1179
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
Immunology Abstracts
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
Public Health Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
ProQuest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
Health & Medical Collection (Alumni)
PML(ProQuest Medical Library)
Science Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Public Health
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Immunology Abstracts
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList ProQuest Central Student
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Pharmacy, Therapeutics, & Pharmacology
EISSN 1557-8852
EndPage 33
ExternalDocumentID 2992505691
23134220
27090714
10_1089_cbr_2012_1179
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.GJ
0R~
29B
34G
39C
4.4
53G
5GY
5RE
6PF
7X7
88E
88I
8C1
8FE
8FH
8FI
8FJ
8WZ
A6W
AAWTL
AAYXX
ABBKN
ABJNI
ABUWG
ACGFS
ACGOD
ACPRK
ADBBV
AENEX
AFKRA
AFRAH
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AZQEC
BBNVY
BENPR
BHPHI
BNQNF
BPHCQ
BVXVI
CAG
CCPQU
CITATION
COF
CS3
DU5
DWQXO
EBS
EJD
F5P
FYUFA
GNUQQ
HCIFZ
HMCUK
IAO
IHR
IM4
INH
INR
ITC
L7B
LK8
M1P
M2P
M7P
O9-
P2P
PHGZM
PHGZT
PQQKQ
PROAC
PSQYO
RIG
RML
RMSOB
UDS
UE5
UKHRP
ZGI
IQODW
PJZUB
PPXIY
PQGLB
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QP
7T5
7TK
7XB
88A
8FK
H94
K9.
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
ID FETCH-LOGICAL-c351t-c6b3917221c7e41b8da4803542b12092f7adc8931f1f9908740d19f10ac537d03
IEDL.DBID 7X7
ISSN 1084-9785
1557-8852
IngestDate Tue Aug 05 09:39:13 EDT 2025
Fri Aug 15 23:00:41 EDT 2025
Thu Apr 03 07:01:50 EDT 2025
Mon Jul 21 09:12:07 EDT 2025
Tue Jul 01 02:47:24 EDT 2025
Thu Apr 24 23:07:49 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Radionuclide study
2-deoxy-2-fluoroglucose
Rectal disease
carbonated water
Colon cancer
colon rectal cancer
Peritoneal carcinomatosis
Intestinal disease
Diagnosis
Anorectal disease
Human
Radiodiagnosis
Fludeoxyglucose (18F)
Malignant tumor
Rectum cancer
Carbonated beverage
Colonic disease
Abdominal disease
PET/CT
Digestive diseases
Medical imagery
Computerized axial tomography
Positron emission tomography
Cancer
Emission tomography
Language English
License http://www.liebertpub.com/nv/resources-tools/text-and-data-mining-policy/121
CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c351t-c6b3917221c7e41b8da4803542b12092f7adc8931f1f9908740d19f10ac537d03
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 23134220
PQID 1366355893
PQPubID 33066
PageCount 5
ParticipantIDs proquest_miscellaneous_1273381362
proquest_journals_1366355893
pubmed_primary_23134220
pascalfrancis_primary_27090714
crossref_citationtrail_10_1089_cbr_2012_1179
crossref_primary_10_1089_cbr_2012_1179
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2013-02-01
PublicationDateYYYYMMDD 2013-02-01
PublicationDate_xml – month: 02
  year: 2013
  text: 2013-02-01
  day: 01
PublicationDecade 2010
PublicationPlace New Rochelle, NY
PublicationPlace_xml – name: New Rochelle, NY
– name: United States
– name: New Rochelle
PublicationTitle Cancer biotherapy & radiopharmaceuticals
PublicationTitleAlternate Cancer Biother Radiopharm
PublicationYear 2013
Publisher Liebert
Mary Ann Liebert, Inc
Publisher_xml – name: Liebert
– name: Mary Ann Liebert, Inc
References Suzuki A (B8) 2004; 10
B10
B11
B12
B14
B15
B16
Boudiaf M (B2) 1999; 53
B17
B18
B19
Gryspeerdt S (B3) 1998; 19
B1
B4
Turlakow A (B5) 2003; 44
B6
B7
B9
Nakamoto Y (B13); 2002
References_xml – volume: 53
  start-page: 115
  year: 1999
  ident: B2
  publication-title: Ann Chir
– volume: 19
  start-page: 434
  year: 1998
  ident: B3
  publication-title: Eur J Gynaecol Oncol
– ident: B16
  doi: 10.1097/01.RLU.0000067510.43457.52
– ident: B19
  doi: 10.1097/PAS.0b013e318205df36
– ident: B7
  doi: 10.1111/j.1749-6632.2011.06077.x
– ident: B12
  doi: 10.1016/S1095-0397(99)00016-3
– ident: B14
  doi: 10.1007/s00330-009-1527-y
– ident: B11
  doi: 10.2967/jnumed.108.057307
– ident: B6
  doi: 10.1089/108497804773391621
– ident: B9
  doi: 10.2214/AJR.09.2936
– ident: B18
  doi: 10.1016/S0016-5085(99)70278-7
– ident: B4
  doi: 10.1055/s-1999-270
– volume: 44
  start-page: 1407
  year: 2003
  ident: B5
  publication-title: J Nucl Med
– ident: B1
  doi: 10.1016/S0016-5085(97)70119-7
– ident: B17
  doi: 10.1097/00003072-199802000-00008
– ident: B15
  doi: 10.1097/00042737-200209000-00010
– volume: 10
  start-page: 1413
  year: 2004
  ident: B8
  publication-title: Eur J Nucl Med Mol Imaging
– ident: B10
  doi: 10.1055/s-0038-1625195
– volume: 2002
  start-page: 171
  ident: B13
  publication-title: Mol Imaging Biol
SSID ssj0006067
Score 2.008002
Snippet Fluorodeoxygluose (FDG) positron emission/computed tomography (PET/CT) is emerging as a useful tool for the diagnosis of peritoneal carcinomatosis (PC). In...
Background: Fluorodeoxygluose (FDG) positron emission/computed tomography (PET/CT) is emerging as a useful tool for the diagnosis of peritoneal carcinomatosis...
SourceID proquest
pubmed
pascalfrancis
crossref
SourceType Aggregation Database
Index Database
Enrichment Source
StartPage 29
SubjectTerms Abdomen
Adult
Aged
Biological and medical sciences
Carbonated Water - administration & dosage
Colonic Neoplasms - diagnostic imaging
Colonic Neoplasms - pathology
Digestion. Liver. Biliary tract. Spleen. Pancreas
Female
Fluorodeoxyglucose F18
Gastroenterology. Liver. Pancreas. Abdomen
Humans
Investigative techniques, diagnostic techniques (general aspects)
Male
Medical sciences
Middle Aged
Peritoneal Neoplasms - diagnostic imaging
Peritoneal Neoplasms - secondary
Positron-Emission Tomography
Prognosis
Radionuclide investigations
Radiopharmaceuticals
Rectal Neoplasms - diagnostic imaging
Rectal Neoplasms - pathology
Time Factors
Tomography, X-Ray Computed
Tumors
Title Usefulness of Dual-Time Point Imaging After Carbonated Water for the Fluorodeoxyglucose Positron Emission Imaging of Peritoneal Carcinomatosis in Colon Cancer
URI https://www.ncbi.nlm.nih.gov/pubmed/23134220
https://www.proquest.com/docview/1366355893
https://www.proquest.com/docview/1273381362
Volume 28
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdgk3hhCAaMwKiMhPrUaP5I6uQJjdBqIG2K0Cr6FiWOLU0qSdc0Ev1n-Fu5S9xUexgvkZI4duK7-H7n-yLkM6BUpYwtfV1oUFBsIP3CMgankgkjS6U1RiNf30yvFsGPZbh0G26Nc6vcr4ndQl3WGvfIL7jsZCOI1y_rex-rRqF11ZXQeEqOMXUZunSp5aBwMQDnqnewD3zQlkKXY5NF8YUuMBkoF2i0jB_IpOfrvIHpsX1di8eBZyeA5i_JC4cc6WVP6lfkialOybNrZxs_JeO0z0K9m9DbQ1BVM6Fjmh7yU-9ek7-Lxth2hWscrS391uYrHyNBaFrfVVv6_XdXuIheYvVwmuSbAjfYTUl_5XgBQC4F0Ejnq7aGxdfUf3bO7R2eh8na1BWdAfPgLtzQFwyTAqtj4m_4hATrF1U1YGV4oKF3FU3g1eCIHLh5Qxbz2W1y5bsyDb6WId_6elpIUPqE4FqZgBdRmQcRk2EgCgzMFVblpQa6ccstyD6sAVjy2HKW61Cqksm35KiC8d8RanlkgnhqeA44TXFRhHEeK9CVQw23eOSRyZ5QmXY5zLGUxirrbOlRnAFdM6QrJjGPPTIemq_75B2PNRw9oPrQWigWY4iXR873bJC5n7zJDizpkU_DbZhhtLnklalbaAPwEEARwASPnPXsc-hcchkIwd7_v_MP5ESgRQwDOjs_mnNytN205iOgoW0x6lgejlHCR-T46-wm_fkPErELbQ
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwED-NToJJCMH4FxjDSNCnRovtpEkeEBpdq5atVYVasbcscWxpUpeUphX0y_AR-IzcJWmrPYy3vVRK49ht7nz-nc93P4CPiFJ9X5vUVolCB8W40k6M4-CldISWqa8UZSMPR-3-1P126V3uwd9NLgwdq9zYxNJQp7miPfITLsu1EZfXL_OfNrFGUXR1Q6FRqcW5Xv9Cl634PDhD-X4SoteddPp2zSpgK-nxpa3aiUQfRQiufO3yJEhjN3Ck54qE8kiF8eNU4TDccIOmmijrUh4a7sTKk37qSOz3Aey7El2ZBux_7Y7G37e2H90BvzrS79ron3l1VU8nCE9UQuVHuaAwaXhrFXw8jwsUiKmYNO6GuuWS13sKT2qsyk4r5XoGezo7hIfDOhp_CM1xVfd63WKTXRpX0WJNNt5VxF4_hz_TQpvVjKwqyw07W8Uzm3JP2Di_zpZscFNSJbFT4itnnXiR0Ja-TtmPmL5AWM0QprLebJWjudf573V90B6fR_Es8ox1UV1p32_bFw4zxslFpcbxL3SIMSnLEZ3jAwW7zlgHfxp-ks4vXsD0XkT4EhoZjv8amOGBdsO25jEiQ5-LxAvj0Efv3FN4iwcWtDaCilRdNZ3IO2ZRGb0PwgjlGpFcqWx6aEFz23xelQu5q-HxLalvWwvfCSmpzIKjjRpEtVkpot0ksODD9ja-YYryxJnOV9gGASnCMAQmFryq1GfXueTSFcJ58__O38Oj_mR4EV0MRudv4UCUDCB0gucIGsvFSr9DHLZMjmvlZ3B13_PtH1OGRDw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VIlVICEGBEihlkSCnWPHu2ln7gFCVNGoorXxoRG7GXu9KlYId4kSQP8MP4dcx40eiHsqtl0iJ17uO57Hf7LwAPiBKVcrYzNGpRgPFetJJreviV-kKIzOlNWUjX14Nzqfel5k_24O_bS4MhVW2OrFS1Fmh6Yy8z2W1N-L22rdNWEQ0Gn9e_HSogxR5Wtt2GjWLXJjNLzTfyk-TEdL6oxDjs-vhudN0GHC09PnK0YNUor0iBNfKeDwNssQLXOl7IqWcUmFVkmlckltuUW1T-7qMh5a7ifalylyJ8z6AhwonIxlTs62x56JhoOrgfs9BS81v6nu6QdjXKRUi5YIcpuGt_fDxIimRNLbuqXE36K02v_FTeNKgVnZas9kz2DP5IRxcNn75Q-hGdQXsTY9d7xK6yh7rsmhXG3vzHP5MS4MvlvQrKywbrZO5Q1koLCpu8hWb_KiaJrFT6lzOhskypcN9k7FvCf2AAJshYGXj-bpAxW-K35sm5B7vR-Isi5ydIePSCeB2LlwmQjGjouP4F4bUOykvEKfjDSW7ydkQHw0_ifuXL2B6LwR8Cfs5rv8KmOWB8cKB4QliRMVF6odJqNBO9zVe4kEHei2hYt3UT6c2HvO48uMHYYx0jYmuVEA97EB3O3xRFw65a-DJLapvRwvlhpRe1oHjlg3iRsGU8U4cOvB-exnfMPl7ktwUaxyD0BQBGUKUDhzV7LObXHLpCeG-_v_k7-AApSz-Orm6eAOPRNUKhEJ5jmF_tVybtwjIVulJxfkMvt-3qP0D6kVHDA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Usefulness+of+Dual-Time+Point+Imaging+After+Carbonated+Water+for+the+Fluorodeoxyglucose+Positron+Emission+Imaging+of+Peritoneal+Carcinomatosis+in+Colon+Cancer&rft.jtitle=Cancer+biotherapy+%26+radiopharmaceuticals&rft.au=Filippi%2C+Luca&rft.au=D%27Arienzo%2C+Marco&rft.au=Scopinaro%2C+Francesco&rft.au=Salvatori%2C+Rita&rft.date=2013-02-01&rft.issn=1084-9785&rft.eissn=1557-8852&rft.volume=28&rft.issue=1&rft.spage=29&rft.epage=33&rft_id=info:doi/10.1089%2Fcbr.2012.1179&rft.externalDBID=n%2Fa&rft.externalDocID=10_1089_cbr_2012_1179
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1084-9785&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1084-9785&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1084-9785&client=summon